Shanghai Sanyou Medical Co., Ltd. (688085.SS)
CNY 20.26
(-2.78%)
CNY 20.26
(-2.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 95.58 Million CNY | -49.91% |
| 2022 | 190.81 Million CNY | 2.39% |
| 2021 | 186.36 Million CNY | 57.2% |
| 2020 | 118.55 Million CNY | 21.2% |
| 2019 | 97.81 Million CNY | 57.42% |
| 2018 | 62.13 Million CNY | 1094.48% |
| 2017 | 5.2 Million CNY | 66.22% |
| 2016 | 3.12 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.77 Million CNY | 279.97% |
| 2024 Q1 | -2.09 Million CNY | -107.15% |
| 2024 Q3 | 6.89 Million CNY | 82.78% |
| 2023 Q2 | 28.26 Million CNY | -18.44% |
| 2023 Q3 | 3.37 Million CNY | -88.07% |
| 2023 Q4 | 29.29 Million CNY | 769.04% |
| 2023 Q1 | 34.65 Million CNY | -47.66% |
| 2023 FY | 95.58 Million CNY | -49.91% |
| 2022 Q4 | 66.2 Million CNY | 38.04% |
| 2022 Q3 | 47.95 Million CNY | 10.28% |
| 2022 Q2 | 43.48 Million CNY | 31.12% |
| 2022 Q1 | 33.16 Million CNY | -54.52% |
| 2022 FY | 190.81 Million CNY | 2.39% |
| 2021 Q1 | 29.94 Million CNY | -22.73% |
| 2021 FY | 186.36 Million CNY | 57.2% |
| 2021 Q4 | 72.92 Million CNY | 69.67% |
| 2021 Q3 | 42.98 Million CNY | 6.09% |
| 2021 Q2 | 40.51 Million CNY | 35.29% |
| 2020 FY | 118.55 Million CNY | 21.2% |
| 2020 Q4 | 38.75 Million CNY | -7.26% |
| 2020 Q3 | 41.78 Million CNY | 60.1% |
| 2020 Q2 | 26.1 Million CNY | 119.15% |
| 2020 Q1 | 11.91 Million CNY | -51.82% |
| 2019 Q1 | 19.58 Million CNY | 7.0% |
| 2019 FY | 97.81 Million CNY | 57.42% |
| 2019 Q4 | 24.72 Million CNY | 4.43% |
| 2019 Q3 | 23.67 Million CNY | -20.66% |
| 2019 Q2 | 29.83 Million CNY | 52.37% |
| 2018 FY | 62.13 Million CNY | 1094.48% |
| 2018 Q4 | 18.3 Million CNY | 0.0% |
| 2017 FY | 5.2 Million CNY | 66.22% |
| 2016 FY | 3.12 Million CNY | 0.0% |